Compare HP Inc (HPQ) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HP Inc vs TG Therapeutics Inc — how do they compare? HP Inc trades at $24.82 (market cap $22.15B), while TG Therapeutics Inc trades at $54 (market cap $8.26B). The key difference: HP Inc is far larger — about 2.7× TG Therapeutics Inc's market cap, and HP Inc pays a 4.95% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HPQ | TGTX | |
|---|---|---|
Market Cap | $22.15B | $8.26B |
Sector | Technology | Health |
52-Week High | $29.35 | $59.06 |
52-Week Low | $18.20 | $26.39 |
Enterprise Value | $29.31B | $8.50B |
Dividend Yield | 4.95% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HPQ trades at $24.81, down 0.12% on the day, with a bullish technical signal from moving averages and a neutral RSI. The stock shows attractive valuation with a P/E of 8.97 and P/S of 0.4, supported by consistent earnings beats in recent quarters. Recent news highlights AI-driven upgrade cycles and strategic partnerships, including with OpenAI, positioning HP for growth in the AI PC market. Cash flow trends have improved, with net cash flow turning positive in 2025.
The outlook for HPQ is cautiously optimistic, driven by potential AI PC adoption and solid fundamentals, but risks include competitive pressures and cyclical demand. Analyst consensus is mixed with a hold rating, and the current price is above the consensus target of $22.00, suggesting limited near-term upside. Investors should weigh the dividend yield and valuation against market volatility and execution risks.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HP Inc
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
